Kym Whitley partners with Eli Lilly to share her transformative experience using Zepbound, an obesity management medication.

Recently released results from a clinical trial on orforglipron show that the oral medication can cause impressive weight ...

Eli Lilly, the pharmaceutical company behind GLP-1 injection Zepbound, is working to bring its weight loss drug to the market in pill form. In an Aug. 7 earnings call, Eli Lilly C ...

Drugmaker Eli Lilly says their oral, daily GLP-1 pill, orforglipron, may offer similar weight loss results as weekly GLP-1 ...

U.S. stocks are drifting lower on Thursday after U.S. President Donald Trump’s latest tariffs took effect on dozens of ...